Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1152-1159, doi:10.1016/j.jacc.2008.07.009
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodondi, N.
Right arrow Articles by Newman, A. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rodondi, N.
Right arrow Articles by Newman, A. B.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: HEART FAILURE

Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure

The Cardiovascular Health Study

Nicolas Rodondi, MD, MAS*,*, Douglas C. Bauer, MD{dagger},{ddagger}, Anne R. Cappola, MD, ScM§, Jacques Cornuz, MD, MPH*, John Robbins, MD, MHS||, Linda P. Fried, MD, MPH, Paul W. Ladenson, MD#, Eric Vittinghoff, PhD{dagger}, John S. Gottdiener, MD, FACC** and Anne B. Newman, MD, MPH{dagger}{dagger}

* Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
{dagger} Department of Epidemiology and Biostatistics, University of California, San Francisco, California
{ddagger} Division of General Internal Medicine, University of California, Department of Medicine, San Francisco, California
§ Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
|| University of California, Davis, Sacramento, California
Division of Geriatric Medicine and Gerontology and Center on Aging and Health, Johns Hopkins Medical Institutions, Baltimore, Maryland
# Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins, University School of Medicine, Baltimore, Maryland
** Echocardiography Laboratory, Division of Cardiology, University of Maryland Hospital, Baltimore, Maryland
{dagger}{dagger} Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

Manuscript received January 23, 2008; revised manuscript received May 27, 2008, accepted July 10, 2008.

* Reprint requests and correspondence: Dr. Nicolas Rodondi, Department of Ambulatory Care and Community Medicine, University of Lausanne, Bugnon 44, 1011 Lausanne, Switzerland (Email: Nicolas.Rodondi{at}hospvd.ch).

Objectives: The goal of this study was to determine whether subclinical thyroid dysfunction was associated with incident heart failure (HF) and echocardiogram abnormalities.

Background: Subclinical hypothyroidism and hyperthyroidism have been associated with cardiac dysfunction. However, long-term data on the risk of HF are limited.

Methods: We studied 3,044 adults ≥65 years of age who initially were free of HF in the Cardiovascular Health Study. We compared adjudicated HF events over a mean 12-year follow-up and changes in cardiac function over the course of 5 years among euthyroid participants, those with subclinical hypothyroidism (subdivided by thyroid-stimulating hormone [TSH] levels: 4.5 to 9.9, ≥10.0 mU/l), and those with subclinical hyperthyroidism.

Results: Over the course of 12 years, 736 participants developed HF events. Participants with TSH ≥10.0 mU/l had a greater incidence of HF compared with euthyroid participants (41.7 vs. 22.9 per 1,000 person years, p = 0.01; adjusted hazard ratio: 1.88; 95% confidence interval: 1.05 to 3.34). Baseline peak E velocity, which is an echocardiographic measurement of diastolic function associated with incident HF in the CHS cohort, was greater in those patients with TSH ≥10.0 mU/l compared with euthyroid participants (0.80 m/s vs. 0.72 m/s, p = 0.002). Over the course of 5 years, left ventricular mass increased among those with TSH ≥10.0 mU/l, but other echocardiographic measurements were unchanged. Those patients with TSH 4.5 to 9.9 mU/l or with subclinical hyperthyroidism had no increase in risk of HF.

Conclusions: Compared with euthyroid older adults, those adults with TSH ≥10.0 mU/l have a moderately increased risk of HF and alterations in cardiac function but not older adults with TSH <10.0 mU/l. Clinical trials should assess whether the risk of HF might be ameliorated by thyroxine replacement in individuals with TSH ≥10.0 mU/l.

Key Words: subclinical thyroid dysfunction • heart failure • echocardiography • cohort study

Abbreviations and Acronyms
  CHS = Cardiovascular Health Study
  CI = confidence interval
  CVD = cardiovascular disease
  FT4 = free thyroxine
  HF = heart failure
  HR = hazard ratio
  LV = left ventricular
  RCT = randomized controlled trial
  TSH = thyroid-stimulating hormone


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31-A32. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Akcakoyun, H. Kaya, R. Kargin, S. Pala, Y. Emiroglu, O. Esen, H. Karapinar, Z. Kaya, and A. M. Esen
Abnormal Left Ventricular Longitudinal Functional Reserve Assessed by Exercise Pulsed Wave Tissue Doppler Imaging in Patients with Subclinical Hypothyroidism
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2979 - 2983.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement